Literature DB >> 25683117

Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB.

Frank Rauch1, Somayyeh Fahiminiya2, Jacek Majewski2, Jian Carrot-Zhang2, Sergei Boudko3, Francis Glorieux4, John S Mort4, Hans-Peter Bächinger3, Pierre Moffatt4.   

Abstract

Cole-Carpenter syndrome is a severe bone fragility disorder that is characterized by frequent fractures, craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features. To identify the cause of Cole-Carpenter syndrome in the two individuals whose clinical results were presented in the original description of this disorder, we performed whole-exome sequencing of genomic DNA samples from both individuals. The two unrelated individuals had the same heterozygous missense mutation in exon 9 of P4HB (NM_000918.3: c.1178A>G [p.Tyr393Cys]), the gene that encodes protein disulfide isomerase (PDI). In one individual, the P4HB mutation had arisen de novo, whereas in the other the mutation was transmitted from the clinically unaffected father who was a mosaic carrier of the variant. The mutation was located in the C-terminal disulfide isomerase domain of PDI, sterically close to the enzymatic center, and affected disulfide isomerase activity in vitro. Skin fibroblasts showed signs of increased endoplasmic reticulum stress, but despite the reported importance of PDI for collagen type I production, the rate of collagen type I secretion appeared normal. In conclusion, Cole-Carpenter syndrome is caused by a specific de novo mutation in P4HB that impairs the disulfide isomerase activity of PDI.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25683117      PMCID: PMC4375435          DOI: 10.1016/j.ajhg.2014.12.027

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

Review 1.  The protein disulfide isomerase family: key players in health and disease.

Authors:  Adam M Benham
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Mutations in WNT1 are a cause of osteogenesis imperfecta.

Authors:  Somayyeh Fahiminiya; Jacek Majewski; John Mort; Pierre Moffatt; Francis H Glorieux; Frank Rauch
Journal:  J Med Genet       Date:  2013-02-23       Impact factor: 6.318

3.  Protein folding drives disulfide formation.

Authors:  Pallav Kosuri; Jorge Alegre-Cebollada; Jason Feng; Anna Kaplan; Alvaro Inglés-Prieto; Carmen L Badilla; Brent R Stockwell; Jose M Sanchez-Ruiz; Arne Holmgren; Julio M Fernández
Journal:  Cell       Date:  2012-11-09       Impact factor: 41.582

Review 4.  A molecular ensemble in the rER for procollagen maturation.

Authors:  Yoshihiro Ishikawa; Hans Peter Bächinger
Journal:  Biochim Biophys Acta       Date:  2013-04-18

5.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

6.  Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density.

Authors:  Somayyeh Fahiminiya; Jacek Majewski; Peter Roughley; Paul Roschger; Klaus Klaushofer; Frank Rauch
Journal:  Bone       Date:  2013-07-23       Impact factor: 4.398

Review 7.  New genes in bone development: what's new in osteogenesis imperfecta.

Authors:  Joan C Marini; Angela R Blissett
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

8.  Extracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammation.

Authors:  Eunsil Hahm; Jing Li; Kyungho Kim; Sungjin Huh; Snezna Rogelj; Jaehyung Cho
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

9.  Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.

Authors:  Donna M McDonald-McGinn; Somayyeh Fahiminiya; Timothée Revil; Beata A Nowakowska; Joshua Suhl; Alice Bailey; Elisabeth Mlynarski; David R Lynch; Albert C Yan; Larissa T Bilaniuk; Kathleen E Sullivan; Stephen T Warren; Beverly S Emanuel; Joris R Vermeesch; Elaine H Zackai; Loydie A Jerome-Majewska
Journal:  J Med Genet       Date:  2012-12-11       Impact factor: 6.318

Review 10.  Properties and rates of germline mutations in humans.

Authors:  Catarina D Campbell; Evan E Eichler
Journal:  Trends Genet       Date:  2013-05-16       Impact factor: 11.639

View more
  26 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta.

Authors:  Fang Lv; Xiao-Jie Xu; Jian-Yi Wang; Yi Liu; Jia-Wei Wang; Li-Jie Song; Yu-Wen Song; Yan Jiang; Ou Wang; Wei-Bo Xia; Xiao-Ping Xing; Mei Li
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

3.  Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta.

Authors:  Uschi Lindert; Mary Ann Weis; Jyoti Rai; Frank Seeliger; Ingrid Hausser; Tosso Leeb; David Eyre; Marianne Rohrbach; Cecilia Giunta
Journal:  J Biol Chem       Date:  2015-05-24       Impact factor: 5.157

4.  Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.

Authors:  He Xu; Sydney A Lenhart; Emily Y Chu; Michael B Chavez; Helen F Wimer; Milena Dimori; Martha J Somerman; Roy Morello; Brian L Foster; Nan E Hatch
Journal:  Dev Dyn       Date:  2020-03-12       Impact factor: 3.780

5.  Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase.

Authors:  Stephan Baumann; Thierry Hennet
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

6.  DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum.

Authors:  G Bardai; P Moffatt; F H Glorieux; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-11       Impact factor: 4.507

7.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

Review 8.  Advances in the Classification and Treatment of Osteogenesis Imperfecta.

Authors:  Inas H Thomas; Linda A DiMeglio
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

9.  Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.

Authors:  Y Zeng; L Zhang; W Zhu; H He; H Sheng; Q Tian; F-Y Deng; L-S Zhang; H-G Hu; H-W Deng
Journal:  Osteoporos Int       Date:  2017-07-24       Impact factor: 4.507

10.  Novel mutations in the SEC24D gene in Chinese families with autosomal recessive osteogenesis imperfecta.

Authors:  H Zhang; H Yue; C Wang; J Gu; J He; W Fu; W Hu; Z Zhang
Journal:  Osteoporos Int       Date:  2016-12-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.